Locally delivered TGF-β1 and IGF-1 enhance the fixation of titanium implants: A study in dogs

Acta Orthopaedica

Volumn 77, Issue 5, 2006, Pages 799-805

  Lamberg, Anders ^a,b   Schmidmaier, Gerhard ^c   Søballe, Kjeld ^a,b   Elmengaard, Brian ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; POLYLACTIDE; RESOMER; SOMATOMEDIN C; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BIOMECHANICS; BONE GROWTH; BONE REGENERATION; CANCELLOUS BONE; CONTROLLED STUDY; DOG; ENERGY ABSORPTION; EVALUATION; FIBROSIS; HUMERUS FRACTURE; IMPLANT; MATERIAL COATING; MATERIALS TESTING; MORPHOMETRICS; NONHUMAN; PROSTHESIS FIXATION; RIGIDITY; STRENGTH;

ANIMALS; ARTHROPLASTY, REPLACEMENT; BIOMECHANICS; COATED MATERIALS, BIOCOMPATIBLE; DOGS; HUMERUS; IMPLANTS, EXPERIMENTAL; INSULIN-LIKE GROWTH FACTOR I; MATERIALS TESTING; OSSEOINTEGRATION; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 33749494996     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670610013024     Document Type: Article

References (43)

1. An Y H, Woolf S K, Friedman R J. Pre-clinical in vivo evaluation of orthopaedic bioabsorbable devices. Biomaterials 2000; 21: 2635-52.
2. Aspenberg P, Albrektsson T, Thorngren K G. Local application of growth-factor IGF-1 to healing bone. Experiments with a titanium chamber in rabbits. Acta Orthop Scand 1989; 60: 607-10.
3. Barboza E P, Caula A L, Caula F O, de Souza R O, Geolas N L, Sorensen R G, Li X J, Wikesjo U M. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol 2004; 75: 702-8.
4. Bostman O M. Osteoarthritis of the ankle after foreign-body reaction to absorbable pins and screws: a three- to nine-year follow-up study. J Bone Joint Surg (Br) 1998; 80: 333-8.
5. Coonts B A, Whitman S L, O'Donnell M, Polson A M, Bogle G, Garrett S, Swanbom D D, Fulfs J C, Rodgers P W, Southard G L, Dunn R L. Biodegradation and biocompatibility of a guided tissue regeneration barrier membrane formed from a liquid polymer material. J Biomed Mater Res 1998; 42: 303-11.
6. Dequeker J, Mohan S, Finkelman R D, Aerssens J, Baylink D J. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 1993; 36: 1702-18.
7. Eingartner C, Coerper S, Fritz J, Gaissmaier C, Koveker G, Weise K. Growth factors in distraction osteogenesis. Immuno-histological pattern of TGF-beta1 and IGF-I in human callus induced by distraction osteogenesis. Int Orthop 1999; 23: 253-9.
8. Elmengaard B, Bechtold J E, Soballe K. In vivo effects of RGD-coated titanium implants inserted in two bone-gap models. J Biomed Mater Res A 2005; 75 (2): 249-55.
9. Engelbrecht D J, Weber F A, Sweet M B, Jakim I. Long-term results of revision total hip arthroplasty. J Bone Joint Surg (Br) 1990; 72: 41-5.
10. Engh C A, Glassman A H, Griffin W L, Mayer J G. Results of cementless revision for failed cemented total hip arthroplasty. Clin Orthop 1988; [235]: 91-110.
11. Geesink R G. Osteoconductive coatings for total joint arthroplasty. Clin Orthop 2002; [395]: 53-65.
12. Glassman A H, Engh C A, Bobyn J D. Proximal femoral osteotomy as an adjunct in cementless revision total hip arthroplasty. J Arthroplasty 1987; 2: 47-63.
13. Gotfredsen K, Budtz-Jorgensen E, Jensen L N. A method for preparing and staining histological sections containing titanium implants for light microscopy. Stain Technol 1989; 64: 121-7.
14. Gundersen H J, Bendtsen T F, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard J R, Pakkenberg B, Sorensen F B, Vesterby A. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96: 379-94.
15. Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater J J, Carmouche J, Zhang X, Rubery P T, Rabinowitz J, Samulski R J, Nakamura T, Soballe K, O'Keefe R J, Boyce B F, Schwarz E M. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005; 11: 291-7.
16. Kandziora F, Pflugmacher R, Scholz M, Schafer J, Schollmeier G, Schmidmaier G, Duda G, Raschke M, Haas N P. Dose-dependent effects of combined IGF-I and TGF-beta1 application in a sheep cervical spine fusion model. Eur Spine J 2003; 12: 464-73.
17. Kveiborg M, Flyvbjerg A, Eriksen E F, Kassem M. Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. J Endocrinol 2001; 169: 549-61.
18. Laffargue P, Fialdes P, Frayssinet P, Rtaimate M, Hildebrand H F, Marchandise X. Adsorption and release of insulin-like growth factor-I on porous tricalcium phosphate implant. J Biomed Mater Res 2000; 49: 415-21.
19. Lammens J, Liu Z, Aerssens J, Dequeker J, Fabry G. Distraction bone healing versus osteotomy healing: a comparative biochemical analysis. J Bone Miner Res 1998; 13: 279-86.
20. Lee Y M, Park Y J, Lee S J, Ku Y, Han S B, Klokkevold P R, Chung C P. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier. J Periodontol 2000; 71: 418-24.
21. Lind M, Overgaard S, Nguyen T, Ongpipattanakul B, Bunger C, Soballe K. Transforming growth factor-beta stimulates bone ongrowth. Hydroxyapatite-coated implants studied in dogs. Acta Orthop Scand 1996a; 67: 611-6.
22. Lind M, Overgaard S, Soballe K, Nguyen T, Ongpipattanakul B, Bunger C. Transforming growth factor-beta 1 enhances bone healing to unloaded tricalcium phosphate coated implants: an experimental study in dogs. J Orthop Res 1996b; 14: 343-50.
23. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman R D, Baylink D J, Farley J R. Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 1994; 78: 1011-6.
24. Noble P C, Alexander J W, Lindahl L J, Yew D T, Granberry W M, Tullos H S. The anatomic basis of femoral component design. Clin Orthop 1988; [235]: 148-65.
25. Overgaard S, Soballe K, Gundersen HJ. Efficiency of systematic sampling in histomorphometric bone research illustrated by hydroxyapatite-coated implants: optimizing the stereological vertical-section design. J Orthop Res 2000; 18: 313-21.
26. Paivarinta U, Bostman O, Majola A, Toivonen T, Tormala P, Rokkanen P. Intraosseous cellular response to biodegradable fracture fixation screws made of polyglycolide or polylactide. Arch Orthop Trauma Surg 1993; 112: 71-4.
27. Park Y J, Lee Y M, Lee J Y, Seol Y J, Chung C P, Lee S J. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J Control Release 2000; 67: 385-94.
28. Pfeilschifter J, Erdmann J, Storch S, Ziegler R, Weinreb M. Changes in the concentration of insulin-like growth factor I and transforming growth factor beta1 in rat femoral bone during growth. Calcif Tissue Int 1999; 64: 78-82.
29. Rose F R, Hou Q, Oreffo R O. Delivery systems for bone growth factors - the new players in skeletal regeneration. J Pharm Pharmacol 2004; 56: 415-27.
30. Schimmel J W, Huiskes R. Primary fit of the Lord cementless total hip. A geometric study in cadavers. Acta Orthop Scand 1988; 59: 638-42.
31. Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberger A, Flyvbjerg A, Haas N P, Raschke M. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 2001a; 28: 341-50.
32. Schmidmaier G, Wildemann B, Stemberger A, Haas N P, Raschke M. Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res 2001b; 58: 449-55.
33. Schmidmaier G, Wildemann B, Gabelein T, Heeger J, Kandziora F, Haas N P, Raschke M. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand 2003; 74: 604-10.
34. Schmidmaier G, Wildemann B, Ostapowicz D, Kandziora F, Stange R, Haas N P, Raschke M. Long-term effects of local growth factor (IGF-I and TGF-beta 1) treatment on fracture healing. A safety study for using growth factors. J Orthop Res 2004; 22: 514-9.
35. Soballe K, Hansen E S, Brockstedt-Rasmussen H, Pedersen C M, Bunger C. Hydroxyapatite coating enhances fixation of porous coated implants. A comparison in dogs between press fit and noninterference fit. Acta Orthop Scand 1990; 61: 299-306.
36. Soballe K, Hansen E S, Rasmussen H, Jorgensen P H, Bunger C. Tissue ingrowth into titanium and hydroxyapatite-coated implants during stable and unstable mechanical conditions. J Orthop Res 1992; 10: 285-99.
37. Soballe K, Hansen E S, Brockstedt-Rasmussen H, Bunger C. Hydroxyapatite coating converts fibrous tissue to bone around loaded implants. J Bone Joint Surg (Br) 1993; 75: 270-8.
38. Soballe K, Jensen T B, Mouzin O, Kidder L, Bechtold J E. Differential effect of a bone morphogenetic protein-7 (OP-1) on primary and revision loaded, stable implants with allograft. J Biomed Mater Res A 2004; 71: 569-76.
39. Thaller S R, Dart A, Tesluk H. The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague-Dawley rats. Ann Plast Surg 1993; 31: 429-33.
40. Tielinen L, Manninen M, Puolakkainen P, Kellomaki M, Tormala P, Rich J, Seppala J, Rokkanen P. Inability of transforming growth factor-beta 1, combined with a bioabsorbable polymer paste, to promote healing of bone defects in the rat distal femur. Arch Orthop Trauma Surg 2001; 121: 191-6.
41. Vehof J W, Haus M T, de Ruijter A E, Spauwen P H, Jansen J A. Bone formation in transforming growth factor beta-I-loaded titanium fiber mesh implants. Clin Oral Implants Res 2002; 13: 94-102.
42. Wildemann B, Sander A, Schwabe P, Lucke M, Stockle U, Raschke M, Haas N P, Schmidmaier G. Short term in vivo biocompatibility testing of biodegradable poly(D,L-lactide)-growth factor coating for orthopaedic implants. Biomaterials 2005; 26: 4035-40.
43. Zellin G, Beck S, Hardwick R, Linde A. Opposite effects of recombinant human transforming growth factor-beta 1 on bone regeneration in vivo: effects of exclusion of periosteal cells by microporous membrane. Bone 1998; 22: 613-20.